Ultralight | $9,300,000 | (Apr 21, 2026)
Sage Haven | $3,000,000 | (Apr 21, 2026)
CREAO AI | $10,000,000 | (Apr 21, 2026)
Certified by Founder
Lodge
Sionna Therapeutics
start up
United States
- Boston, MA
- 07/03/2024
- Series C
- $182,000,000
We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF.
- Industry Biotechnology
- Website https://www.sionnatx.com/
- LinkedIn https://www.linkedin.com/company/sionna-therapeutics/
ViewsML | $4,900,000 | (Apr 21, 2026)
Antioch | $8,500,000 | (Apr 21, 2026)
Wavelet Medical | $7,000,000 | (Apr 21, 2026)
Rivan Industries | $34,000,000 | (Apr 21, 2026)
urfuture | $2,299,785 | (Apr 21, 2026)
TraqCheck | $8,000,000 | (Apr 21, 2026)
Giggles | $1,000,000 | (Apr 21, 2026)
brainjo GmbH | $2,356,020 | (Apr 21, 2026)
Coral(US) | $12,500,000 | (Apr 21, 2026)